Hereditary Cancer Services

Genetic counselors help patients make informed healthcare decisions by delivering expert, technical genetic information to patients in practical and useful terms. At Integrated Genetics and Integrated Oncology, all of our genetic counselors are board certified by the American Board of Genetic Counseling or are active candidates for certification.  We have been providing genetic counseling services in women’s health for more than 20 years.  Our trained and experienced professionals understand the complexities of hereditary cancer and can bring genetic expertise into your practice by providing genetic counseling services to you and your patients. 

Genetic Counseling Services 

Integrated Genetics and Integrated Oncology provide nationwide access to our genetic counseling service offerings for hereditary cancer, including:

  • Pretest genetic counseling for patients at risk for a hereditary cancer due to a personal or family history of breast, ovarian, colon, endometrial and /or pancreatic cancer
  • Recommendations provided for appropriate testing according to established guidelines
  • Post-test genetic counseling to discuss the implications of genetic testing results
  • Summary genetic counseling report provided to referring physician, outlining the family history,  testing options discussed with the patient, and patient  decisions
  • Hereditary cancer  educational programs for medical practice and staff
  • Physician consultations with genetic counselors by telephone for case discussion and questions

Genetic counseling can be provided by telegenetics or in-person sessions (where available), allowing for increased access and convenience for more patients.

Our genetic counseling sessions provide the following to patients:

 Genetic Risk Assessment    Patient Education    Patient Information
  • Evaluation of family history of cancers
  • Review of relevant laboratory results and medical records
  • Assessment of risk to develop cancer and to carry an inherited genetic  mutation
  • Overview of genetic testing for hereditary cancers
  • Implications of test results on surveillance and treatment options


  • Support for informed decision making
  • Discussion of heritability of cancer risk and impact on other family members
  • Referral to community resources


Which patients could be referred for hereditary cancer genetic counseling?

Those with a personal or family history of:

  • Cancer diagnosed at an earlier age than expected
  • More than one type of cancer in the same person, such as breast and ovarian
  • Breast cancer in an individual of Ashkenazi Jewish ancestry
  • Cancers occurring in both of a pair of organs such as the breasts
  • Ovarian cancer
  • Male breast cancer
  • Triple-negative (estrogen receptor negative, progesterone receptor negative, and HER2/neu [human epidermal growth factor receptor 2] negative) breast cancer
  •  Clustering of rare cancers within the family
  • Patients with two or more closely related individuals on the same side of the family with similar or related types of cancer such as breast, ovarian, pancreatic, prostate, endometrial, and colon
  • A previously identified BRCA1, BRCA2 or Lynch syndrome mutation in the family
  • Patients who meet the NCCN Guidelines® for breast and/or ovarian cancer or colon cancer genetic assessment,1,2
  • Patients with concerns or questions about their family history of breast or ovarian cancer

The Integrated Difference

Genetic counseling provided by Integrated Genetics and Integrated Oncology offer the largest staff of genetic counselors in the country, with a national network capable of providing comprehensive genetic counseling to your patients. If you are interested in our genetic counseling services, please speak to your Integrated Genetics or Integrated Oncology sales representative or call 855 GC-CALLS (855 422-2557) to obtain additional information.



  1. Genetic/Familial High-Risk Assessment: Breast and Ovarian.  NCCN Guidelines Version 2.2015   Available at:  Accessed July 24, 2015. 
  2. Genetic/Familial High-Risk Assessment: Colorectal.  NCCN Guidelines Version 1.2015   Available at:  Accessed July 24, 2015.

NCCN Guidelines® is a trademark owned by the National Comprehensive Cancer Network, Inc.